Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582101 · ClinicalTrials.gov registry record · Phase 1
Family-Based HIV Prevention for Latinos
A Phase 1 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00582101: Completed Phase 1 study, sponsored by Rhode Island Hospital.
NCT00582101 is a Phase 1 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582101, a Phase 1 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The proposed project will develop and test an HIV prevention intervention for Latino families. This study will: 1. Conduct a pilot "run-through" of an adapted family-based intervention with three cohorts (about 24 families) to determine the feasibility, acceptability, and appropriateness for the target population. 2. Revise the family-based HIV prevention intervention based on the results of the pilot "run-through" and structured exit interviews. 3. Recruit and randomize 100 families into the Latino family-based HIV prevention intervention or a general health promotion condition. 4. Estimate the effect size of the Latino family-based HIV prevention intervention from assessment of changes in HIV-related sexual behavior and attitudes and parental monitoring/supervision over 6 months. Based on a thorough review of the literature, the following is anticipated: 1. The revised intervention will be feasible, acceptable, and appropriate for Latino families and will be enthusiastically received. 2. The family-based HIV prevention intervention will result in safer adolescent sexual behavior, greater change with regard to primary outcome measures of behavior (recent sexual activity, the number of unprotected sex acts, proportion of condom use, and intentions to use condoms), safer HIV-related attitudes, improved parent-child communication skills, and greater parental monitoring than the Latino families in the general health promotion condition.
Interventions
- BEHAVIORAL General Health Promotion
- BEHAVIORAL Family-Based HIV Prevention for Latinos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
What the finished NCT00582101 record still lists
NCT00582101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 2 interventions - of which General Health Promotion is the first listed.
NCT00582101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582101 about?
NCT00582101 is a clinical study titled "Family-Based HIV Prevention for Latinos". The proposed project will develop and test an HIV prevention intervention for Latino families. This study will: 1. Conduct a pilot "run-through" of an adapted family-based intervention with three cohorts (about 24 families) to determine the feasibility, acceptability, and appropriateness for the ta...
What is the current status of trial NCT00582101?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2007-05. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00582101?
The interventions under investigation include: General Health Promotion (BEHAVIORAL), Family-Based HIV Prevention for Latinos (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582101?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00582101's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia